|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/401 | (2006.01) |
| C12Q 1/68 | (2018.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| C12Q 1/6883 | (2018.01) |
| (11) | Number of the document | 3200783 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15790622.3 |
| Date of filing the European patent application | 2015-10-02 | |
| (97) | Date of publication of the European application | 2017-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (86) | Number | PCT/GB2015/052885 |
| Date | 2015-10-02 |
| (87) | Number | WO 2016/051194 |
| Date | 2016-04-07 |
| (30) | Number | Date | Country code |
| 201417497 | 2014-10-03 | GB |
| (72) |
MORISSET, Valerie, GB
|
| (73) |
Convergence Pharmaceuticals Limited,
90 High Holborn, London WC1V 6XX,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Eritromelalgijos gydymas |
| ERYTHROMELALGIA TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2022-09-20 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-02 |